Icon (NASDAQ:ICLR) Downgraded by Rothschild & Co Redburn to “Hold”

Icon (NASDAQ:ICLR) was downgraded by investment analysts at Rothschild & Co Redburn from a “strong-buy” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.

Several other brokerages have also commented on ICLR. BMO Capital Markets reissued a “market perform” rating and issued a $100.00 price objective on shares of Icon in a report on Thursday, February 12th. Truist Financial reaffirmed a “hold” rating and set a $222.00 price objective (down from $231.00) on shares of Icon in a report on Thursday, January 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Icon in a research report on Monday, December 29th. Zacks Research upgraded shares of Icon from a “strong sell” rating to a “hold” rating in a research report on Tuesday, November 25th. Finally, UBS Group set a $220.00 price target on shares of Icon in a research note on Friday, October 24th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $164.33.

Icon Stock Performance

Shares of NASDAQ ICLR opened at $88.62 on Tuesday. The company has a market capitalization of $7.16 billion, a PE ratio of 11.99, a price-to-earnings-growth ratio of 1.96 and a beta of 1.27. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. The company’s fifty day moving average price is $172.29 and its 200 day moving average price is $173.74. Icon has a 1 year low of $66.57 and a 1 year high of $211.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ICLR. Guggenheim Capital LLC acquired a new stake in shares of Icon in the fourth quarter valued at approximately $244,000. AQR Capital Management LLC acquired a new stake in shares of Icon in the 4th quarter worth $308,000. Harris Associates L P increased its stake in shares of Icon by 7.2% in the 4th quarter. Harris Associates L P now owns 2,510,166 shares of the medical research company’s stock worth $457,402,000 after acquiring an additional 167,607 shares during the last quarter. Braidwell LP purchased a new position in shares of Icon during the 4th quarter worth $13,369,000. Finally, EFG International AG purchased a new stake in shares of Icon in the fourth quarter valued at about $27,000. 95.61% of the stock is currently owned by institutional investors and hedge funds.

Icon Company Profile

Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.